Alumiiniumisulam 1350, sageli nimetatakse “1350 alumiiniumfoolium”, on puhas alumiiniumisulam minimaalse alumiiniumisisaldusega 99.5%. Kuigi puhast alumiiniumi farmaatsiapakendites tavaliselt ei kasutata, alumiinium ja selle sulamid (sealhulgas 1350 alumiiniumist) saab pärast nõuetekohast töötlemist ja katmist kasutada ravimipakendis.
Pharmaceutical packaging requires certain properties to ensure the safety and preservation of pharmaceuticals, nagu näiteks:
Barjääri omadused: Packaging materials should provide a barrier against moisture, hapnikku, and other environmental factors to protect the drug product.
Sterility: Pharmaceutical packaging should maintain the sterility of the contents and prevent contamination.
Printability: Packaging materials should be capable of high-quality printing to display important information, bränding, and instructions.
Ease of sealing: Packaging materials should be easy to seal securely to prevent tampering and maintain product integrity.
Ohutus: The material should be safe for direct contact with the drug and should not react with the drug or leach harmful substances into the drug.
Puhas alumiiniumfoolium (sealhulgas 1350 alumiiniumist) may not meet all of these requirements without additional processing and coatings. Tavaliselt, pharmaceutical packaging uses specially treated and coated aluminum foil to enhance its barrier properties, sealing properties and printability.
